Back to search

Article

Spatial-Immune Multi-omics Refines Prognostication in Early-Stage Estrogen Receptor-Positive Breast Cancer

2025-10-12

Abstract excerpt

<title>Abstract</title> <p> Despite a strong 5–10 year prognosis, in ER <sup>+</sup> HER2 <sup>−</sup> breast cancer relapses are common beyond 10 years. Genomic assays employed to determine recurrence risk at diagnosis are still ambiguous for a significant proportion of patients with Intermediate risk (i.e. Oncotype Dx Recurrence Score (RS) 16–25). We demonstrate that macrophage and T-helper cells facilitat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c0cabfd7-ed2a-5d85-9449-0f00f60b8164
DOI
10.21203/rs.3.rs-7726652/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Spatial-Immune Multi-omics Refines Prognostication in Early-Stage Estrogen Receptor-Positive Breast CancerDOI 10.21203/rs.3.rs-7726652/v1
Select a neighboring publication to make it the new centre.